Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

Source:http://linkedlifedata.com/resource/pubmed/id/11704791

Download in:

View as

General Info

PMID
11704791